Rankings
▼
Calendar
CMPX Q1 2022 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$781M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.07
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$147M
Total Liabilities
$12M
Stockholders' Equity
$134M
Cash & Equivalents
$136M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$7M
-$7M
+2.1%
Net Income
-$7M
-$7M
+3.5%
← FY 2022
All Quarters
Q2 2022 →